<DOC>
	<DOCNO>NCT01004107</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness Radiesse® Injectable Dermal Filler hand treatment .</brief_summary>
	<brief_title>Evaluation Radiesse® Dermal Filler Hand Rejuvenation</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Has right leave hand rating 3 4 BHVSS determine treat physician Is least 18 year age Signs write informed consent Understands accepts obligation receive procedure dorsum hand 12 month follow Understands accept obligation logistically able present schedule followup visit Exclusion Criteria Has plan activity study could interfere treatment ( i.e. , box ) impose significant force hand . Has history hypertropic scarring . Has know bleed disorder ( e.g. , thrombocytopenia , thrombasthenia , von Willebrand 's disease ) . Has receive anticipate receive antiplatelets , anticoagulant , thrombolytic , vitamin E antiinflammatories within 2 week pre treatment . Is receive systemic corticosteroid anabolic steroid ( standard dos inhale nasal corticosteroid acceptable ) . Has history chronic recurrent infection ( e.g. , Pseudomona paronychia ) inflammation ( e.g. , rheumatoid arthritis ) would preclude participation study . Has know hypersensitivity component Radiesse local anesthesia . Has receive follow dorsum hand within 4 week treatment intend receive product treatment study : Over thecounter wrinkle product ( e.g. , alphahydroxy acid ) prescription treatment ( e.g. , Renova , RetinA , microdermabrasion , chemical peel ) Has dermal filler surgery dorsum hand . Is female child bear potential use medically effective birth control pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>